首页 > 市场调查报告书 > 製药

再生医学细胞疗法

2030 年亚太地区生物生产市场预测 - 区域分析 - 按产品、应用、设备和最终用户

市场调查报告书

商品编码

1510611

2030 年亚太地区生物生产市场预测 - 区域分析 - 按产品、应用、设备和最终用户

Asia Pacific Bioproduction Market Forecast to 2030 - Regional Analysis - by Product, Application, Equipment, and End User

出版日期: 2024年05月07日 | 出版商:

The Insight Partners | 英文 117 Pages | 订单完成后即时交付

价格

简介目录图表

2022年亚太地区生物生产市场价值为47.9134亿美元，预计2030年将达到146.123亿美元；预计2022年至2030年复合年增长率为15.0%。

重磅生物製剂专利到期提振亚太生物生产市场

生物製品代表了治疗以前无法治癒的疾病的有前途的新疗法，并且在药品市场中变得非常重要。原厂生物製品的专利预计将在未来几年到期。

下表列出了最畅销生物製品的预期专利和独占权到期日。

生物製品有效期限

阿瓦斯汀 2022 年 1 月

西拉姆扎 2023 年 5 月

Adcetris 2023 年 8 月

阿布特拉克斯 2024 年 10 月

加济瓦/加济瓦罗 2024 年 11 月

达札莱克斯 2026 年 5 月

奥克雷乌斯 2027 年 4 月

Emgality 2028 年 9 月

赫姆利布拉 2028 年 2 月

卢梅特里 2028 年 3 月

伊姆芬齐 2028 年 9 月

迈洛塔格 2028 年 4 月

伊姆芬齐 2028 年 9 月

迈洛塔格 2028 年 4 月

西尔万特 2034 年 7 月

原厂生物製品的专利到期和其他智慧财产权将在未来产生推出新生物相似药的需求。因此，未来几年该行业市场参与者之间的竞争将加剧。因此，重磅生物製剂的专利到期预计将在预测期内为生物生产市场创造利润丰厚的机会。

亚太地区生物生产市场概况

亚太地区生物生产市场分为中国、日本、印度、韩国、澳洲、韩国和亚太地区其他地区。由于对优质治疗解决方案的需求不断增长、对研发活动的日益关注以及有利的监管环境等因素，亚太地区市场的成长预计将以更快的速度成长。此外，增加投资和发展医疗基础设施以促进研究活动预计将在 2022 年至 2030 年期间推动亚太地区生物生产市场的发展。

在中国，对医疗保健的需求正在迅速成长。老年人口不断增长、慢性病发病率上升以及政府在医疗保健领域的倡议不断增加等因素正在推动中国细胞治疗市场的发展。基本和私人医疗保险计划的改善也加速了该国医疗行业的成长。收入水准的提高导致了对更复杂的医疗服务的需求。老年人口的增加导致该国专业医学界的增加。在中国，癌症盛行率的不断上升可能会增加细胞疗法的采用。根据中国国家癌症中心登记中心的数据，中国登记了 430 万新发癌症病例。

亚太地区生物生产市场收入及 2030 年预测（百万美元）

亚太地区生物生产市场细分

亚太地区生物生产市场分为产品、应用、设备、最终用户和国家。

根据产品，亚太生物生产市场分为生物製剂和生物相似药、疫苗、细胞和基因疗法、核酸疗法等。 2022 年，生物製剂和生物相似药领域占据亚太地区最大的生物生产市场。

在应用方面，亚太生物生产市场分为类风湿性关节炎、血液疾病、癌症、糖尿病、心血管疾病等。到 2022 年，癌症领域将占据亚太地区最大的生物生产市场。

依设备划分，亚太生物生产市场分为上游设备、下游设备、生物反应器、耗材及配件。 2022 年，消耗品和配件领域占据亚太地区最大的生物生产市场。

就最终用户而言，亚太生物生产市场分为生物製药公司、合约製造组织等。 2022 年，生物製药公司细分市场占据亚太地区最大的生物生产市场。

依国家/地区划分，亚太地区生物生产市场分为澳洲、中国、印度、日本、韩国和亚太地区其他地区。 2022年，中国在亚太生物生产市场份额中占据主导地位。

Lonza Group AG、bbi-biotech GmbH、Danaher Corp、Sartorius AG、FUJIFILM Irvine Scientific Inc、Thermo Fisher Scientific Inc、Merck KGaA、F. Hoffmann-La Roche Ltd 和 Bio-Rad Laboratories Inc. 是一些领先的营运公司亚太生物生产市场。

The patent expiration and other intellectual property rights for originator biologicals will create a need to introduce new biosimilars in the future. As a result, competition among market players will surge in the industry in the coming years. Thus, the patent expiry of blockbuster biologics is expected to create lucrative opportunities for the bioproduction market during the forecast period.

Asia Pacific Bioproduction Market Overview

The Asia Pacific bioproduction market is segmented into China, Japan, India, South Korea, Australia, South Korea, and the Rest of Asia Pacific. The growth of the market in Asia Pacific is anticipated to grow at a faster pace owing to factors such as growing need for superior treatment solutions, increasing focus on research and development activities, and favorable regulatory scenarios. Additionally, increasing investments and developing healthcare infrastructure to boost research activities are estimated to drive the Asia Pacific bioproduction market during 2022-2030.

In China, the demand for healthcare is increasing rapidly. Factors such as growing geriatric population, rising incidence of chronic diseases, and increasing government initiatives in the healthcare sector are driving the cell therapy market in China. Improvements in basic and private medical insurance plans have also accelerated the growth of the medical sector in the country. The rising income levels have led to the demand for more sophisticated healthcare services. The rise in the geriatric population has led to an increase in the specialty medical community in the country. In China, the growing prevalence of cancer is likely to increase the adoption of cell therapy. According to the National Central Cancer Registry of China, 4.3 million new cancer cases were registered in China.

Asia Pacific Bioproduction Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Bioproduction Market Segmentation

The Asia Pacific bioproduction market is categorized into product, application, equipment, end user, and country.

Based on product, the Asia Pacific bioproduction market is segmented into biologics and biosimilars, vaccines, cell and gene therapies, nucleic acid therapeutics, and others. The biologics and biosimilars segment held the largest Asia Pacific bioproduction market share in 2022.

In terms of application, the Asia Pacific bioproduction market is segmented into rheumatoid arthritis, hematological disorders, cancer, diabetes, cardiovascular diseases, and others. The cancer segment held the largest Asia Pacific bioproduction market share in 2022.

By equipment, the Asia Pacific bioproduction market is divided into upstream equipment, downstream equipment, bioreactors, and consumables and accessories. The consumables and accessories segment held the largest Asia Pacific bioproduction market share in 2022.

In terms of end user, the Asia Pacific bioproduction market is categorized into biopharmaceutical companies, contract manufacturing organizations, and others. The biopharmaceutical companies segment held the largest Asia Pacific bioproduction market share in 2022.

By country, the Asia Pacific bioproduction market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific bioproduction market share in 2022.

Lonza Group AG, bbi-biotech GmbH, Danaher Corp, Sartorius AG, FUJIFILM Irvine Scientific Inc, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories Inc. are some of the leading companies operating in the Asia Pacific bioproduction market.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Bioproduction Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rising Adoption of Regenerative Medicines
- 4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
- 4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
- 4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
- 4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis

5. Bioproduction Market - Asia Pacific Market Analysis

5.1 Asia Pacific Bioproduction Market Revenue (US$ Mn), 2020 - 2030

6. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Product

6.1 Overview
6.2 Asia Pacific Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
- 6.3.1 Overview
- 6.3.2 Biologics and Biosimilars: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
- 6.4.1 Overview
- 6.4.2 Vaccines: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
- 6.5.1 Overview
- 6.5.2 Cell and Gene Therapies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
- 6.6.1 Overview
- 6.6.2 Nucleic Acid Therapeutics: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 Asia Pacific Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
- 7.3.1 Overview
- 7.3.2 Cancer: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
- 7.4.1 Overview
- 7.4.2 Cardiovascular Diseases: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
- 7.5.1 Overview
- 7.5.2 Rheumatoid Arthritis: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
- 7.6.1 Overview
- 7.6.2 Hematological Disorders: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
- 7.7.1 Overview
- 7.7.2 Diabetes: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Equipment

8.1 Overview
8.2 Asia Pacific Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
- 8.3.1 Overview
- 8.3.2 Consumables and Accessories: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
- 8.4.1 Overview
- 8.4.2 Downstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
- 8.5.1 Overview
- 8.5.2 Bioreactors: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.5.2.1 Asia Pacific: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
- 8.6.1 Overview
- 8.6.2 Upstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Asia Pacific Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
- 9.3.1 Overview
- 9.3.2 Biopharmaceutical Companies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
- 9.4.1 Overview
- 9.4.2 Contract Manufacturing Organizations: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Asia Pacific: Bioproduction Market
- 10.1.1 Asia Pacific: Bioproduction Market, by Country, 2022 & 2030 (%)
  - 10.1.1.1 China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.2 China: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.1.3 China: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.1.4 China: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.1.4.1 China: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.1.5 China: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.2 India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 India: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.2.4 India: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.2.5 India: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.2.5.1 India: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.2.6 India: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.3 Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 Japan: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.3.4 Japan: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.3.5 Japan: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.3.5.1 Japan: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.3.6 Japan: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.4 Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Australia: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.4.4 Australia: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.4.5 Australia: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.4.5.1 Australia: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.4.6 Australia: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.5 South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.3 South Korea: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.5.4 South Korea: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.5.5 South Korea: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.5.5.1 South Korea: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.5.6 South Korea: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.6 Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.3 Rest of Asia Pacific: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.6.4 Rest of Asia Pacific: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.6.5 Rest of Asia Pacific: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.6.5.1 Rest of Asia Pacific: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.6.6 Rest of Asia Pacific: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)

11. Bioproduction Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 . Lonza Group AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 bbi-biotech GmbH
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Danaher Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Sartorius AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 FUJIFILM Irvine Scientific Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Merck KGaA
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Bio-Rad Laboratories Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Asia Pacific Bioproduction Market Segmentation
Table 2. Asia Pacific Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. China Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. China Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. China Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. China Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. China Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. India Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. India Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. India Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. India Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. India Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Japan Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Japan Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. Japan Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 16. Japan Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. Japan Bioproduction Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 18. Australia Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 19. Australia Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 20. Australia Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 21. Australia Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 22. Australia Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. South Korea Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 24. South Korea Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. South Korea Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 26. South Korea Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 27. South Korea Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 28. Rest of Asia Pacific Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 29. Rest of Asia Pacific Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 30. Rest of Asia Pacific Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Asia Pacific Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Asia Pacific Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 33. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 34. Recent Organic Growth Strategies in the Bioproduction Market
Table 35. Glossary of Terms, Bioproduction Market

List Of Figures

Figure 1. Asia Pacific Bioproduction Market Segmentation, By Country
Figure 2. Asia Pacific Bioproduction Market: Key Industry Dynamics
Figure 3. Asia Pacific Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Asia Pacific Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Asia Pacific Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Asia Pacific Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Asia Pacific: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. Asia Pacific: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Growth Strategies in the Bioproduction Market